Tom Beausejour

BioTom joined MedEquity Capital as a Vice President in 2016 and his primary responsibilities include helping to acquire and operate MedEquity’s portfolio companies. Prior to MedEquity, Tom worked in both corporate and advisory arenas, most recently at Vertex Pharmaceuticals. Vertex is a Boston-based biotechnology firm which develops and commercializes novel drug therapies, most notably those for the treatment of Cysti ....